Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPICKLE trial of sulphadoxine/pyrimethamine versus proguanil for malaria prophylaxis in pregnant women with sickle cell disease
PACTR201802003063273Not yet recruiting
- Sponsor
- European & Developing Countries Clinical Trials Partnership
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of sulfadoxine + pyrimethamine and proguanil in malaria (2 arms), sponsored by European & Developing Countries Clinical Trials Partnership. Primary endpoint: Incidence of malaria parasite at delivery. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
sulfadoxine + pyrimethamineproguanil
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR201802003063273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201802003063273.